Cohort Profile
-
Study protocol for the Korean Human Exposure Safety Survey (KoHESS): a national biomonitoring program for food and consumer product safety
-
Hyeon-Jeong Lim, Sang-Yong Eom, Sun-Haeng Choi, Seonmi Hong, Byung-Sun Choi, Young-Seoub Hong, Kwan Lee, Won-Ju Park, Jae-Seok Song, Nam-Jun Kim, Hyo-Jeong Hwang, Rihwa Choi, Hosub Im, Youn-Seok Kang, Hye-Young Lee, Mi-Ran Kim, Hyunjin Son, Yong-Dae Kim
-
Epidemiol Health. 2025;47:e2025060. Published online October 29, 2025
-
DOI: https://doi.org/10.4178/epih.e2025060
-
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
This protocol paper describes the design and methodology of the Korean Human Exposure Safety Survey (KoHESS), a three-year national biomonitoring program (2023-2025). Korea’s Act on Risk Assessment of Products for Human Use necessitates scientific evidence for aggregate exposure assessment and cumulative risk evaluation of hazardous substances in food and consumer products. Existing biomonitoring programs primarily focus on environmental exposures, limiting comprehensive assessment of products regulated by the Ministry of Food and Drug Safety. KoHESS employs repeated cross-sectional surveys targeting approximately 5,000 Koreans aged 3-79 years per cycle, using complex stratified multistage sampling for national representativeness. Data collection includes standardized anthropometric measurements, biological samples (blood, urine), comprehensive exposure source surveys, and 2-day 24-hour dietary recalls. Chemical analyses using liquid chromatography-tandem mass spectrometry and inductively coupled plasma mass spectrometry measure 24 perfluoroalkyl and polyfluoroalkyl substances compounds, 25 phthalate metabolites, and 7 heavy metals, with quality assurance through certified reference materials. KoHESS will provide scientifically robust data for establishing safety standards, enable advanced exposure modeling, facilitate risk assessments reflecting cumulative exposures, support targeted protection for vulnerable populations, and contribute to international biomonitoring networks while promoting preventive hazardous substance management systems.
-
Summary
Korean summary
- 식품의약품안전처(MFDS)가 주관하는 KoHESS (2023-2025)는 한국을 대표하는 5,000명의 국민(3~79세)을 대상으로 3년간 반복 수행되는 전국 규모의 인체 모니터링 프로그램이다.
- 기존 환경 노출 데이터의 한계를 보완하여 식품 및 소비재 유래 유해 물질(PFAS 24종, 프탈레이트 25종, 중금속 7종)의 인체 노출 수준을 측정한다.
- 수집된 과학적 데이터는 유해 물질의 통합 노출 평가, 누적 위해성 평가 및 제품 안전 기준 설정을 위한 핵심 근거 자료로 활용될 것으로 기대된다.
Key Message
- KoHESS (2023-2025) is a national, repeated cross-sectional biomonitoring program led by the Ministry of Food and Drug Safety (MFDS), targeting 5,000 Koreans (3-79 years) per cycle.
- It measures 24 PFAS, 25 phthalate metabolites, and 7 heavy metals, specifically focusing on hazardous substances from food and consumer products, filling gaps in existing environmental data.
- The data provides robust scientific evidence crucial for aggregate exposure assessment, cumulative risk evaluation, and establishing safety standards for regulated products.
Original Articles
-
Association between psychosocial safety climate and depression risk among Korean workers
-
Soo Kyung Cho, Seong-Sik Cho, Maureen F. Dollard, May Young Loh, Mo-Yeol Kang
-
Epidemiol Health. 2025;47:e2025044. Published online August 13, 2025
-
DOI: https://doi.org/10.4178/epih.e2025044
-
-
Abstract
Summary
PDF
-
Abstract
OBJECTIVES
Psychosocial safety climate (PSC) reflects an organization’s commitment to safeguarding workers’ psychological health and safety. While international evidence links low PSC to poor mental health outcomes, its association with depression has not been well established in Korea. This study aimed to examine the relationship between PSC and depression among Korean workers, utilizing a large-scale, population-based survey.
METHODS
We analyzed data from 5,337 wage employees who participated in the fifth wave of the Korean Work, Sleep, and Health Study. Depression was measured using the 9-item Patient Health Questionnaire, and PSC was assessed with a validated 4-item scale. Participants were classified into low-risk, intermediate-risk, and high-risk groups based on their PSC scores. Multivariable logistic regression was conducted to estimate the association between PSC and depression, with stratified analyses performed according to gender, age, and occupational characteristics.
RESULTS
The prevalence of depression increased as PSC scores decreased. Compared to the low-risk group, the intermediate-risk and high-risk PSC groups exhibited 1.19 times and 2.69 times higher risks of depression, respectively, suggesting a clear exposure-response relationship. Stratified analyses indicated that associations were stronger among individuals without union representation or access to occupational health and safety resources.
CONCLUSIONS
These findings underscore the critical role of PSC in workplace mental health. Promoting a high PSC may help reduce depression risk and support mental well-being among workers. Interventions considering vulnerable subgroups are warranted to create psychologically safer work environments in Korea.
-
Summary
Korean summary
-본 연구에서는 한국 근로자에서 심리사회적 안전풍토(PSC) 점수가 낮을수록 우울 위험이 유의하게 높아짐을 확인하였다.
-PSC 중간위험군과 고위험군의 우울 위험은 저위험군에 비해 각각 1.19배, 2.69배 높았다.
-연구 결과는 근로자의 정신건강 증진과 국가적 정책 수립을 위해 직장에서의 PSC 강화를 강조한다.
Key Message
-This study demonstrates that lower psychosocial safety climate (PSC) scores are associated with a significantly higher risk of depression among Korean workers.
-The risk of depression was 1.19 times higher in the intermediate-risk PSC group and 2.69 times higher in the high-risk PSC group compared with the low-risk group.
-Findings highlight the importance of strengthening PSC in workplaces to improve employee mental health and guide national policies.
-
Identifying adverse reactions following COVID-19 vaccination in Korea using data from active surveillance: a text mining approach
-
Hye Ah Lee, Bomi Park, Chung Ho Kim, Yeonjae Kim, Hyunjin Park, Seunghee Jun, Hyelim Lee, Seunghyun Lewis Kwon, Yesul Heo, Hyungmin Lee, Hyesook Park, COVID-19 Vaccine Safety Research Committee
-
Epidemiol Health. 2025;47:e2025034. Published online June 30, 2025
-
DOI: https://doi.org/10.4178/epih.e2025034
-
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
Unstructured text data collected through vaccine safety surveillance systems can identify previously unreported adverse reactions and provide critical information to enhance these systems. This study explored adverse reactions using text data collected through an active surveillance system following coronavirus disease 2019 (COVID-19) vaccination.
METHODS
We performed text mining on 2,608 and 2,054 records from 2 survey seasons (2023-2024 and 2024-2025), in which participants reported health conditions experienced within 7 days of vaccination using free-text responses. Frequency analysis was conducted to identify key terms, followed by subgroup analyses by sex, age, and concomitant influenza vaccination. In addition, semantic network analysis was used to examine terms reported together.
RESULTS
The analysis identified several common (≥1%) adverse events, such as respiratory symptoms, sleep disturbances, lumbago, and indigestion, which had not been frequently noted in prior literature. Moreover, less frequent (≥0.1 to <1.0%) adverse reactions affecting the eyes, ears, and oral cavity were also detected. These adverse reactions did not differ significantly in frequency based on the presence or absence of simultaneous influenza vaccination. Co-occurrence analysis and estimation of correlation coefficients further revealed associations between frequently co-reported symptoms.
CONCLUSIONS
This study utilized text mining to uncover previously unrecognized adverse reactions associated with COVID-19 vaccination, thereby broadening our understanding of the vaccine’s safety profile. The insights obtained may inform future investigations into vaccine-related adverse reactions and improve the processing of text data in surveillance systems.
-
Summary
Korean summary
* 본 연구는 COVID-19 백신 접종 후 자가 보고된 증상을 텍스트 마이닝으로 분석하여, 이전에 알려지지 않았던 부작용을 확인하였습니다.
* 본 연구 결과는 백신 부작용에 대한 이해를 높이고, 향후 연구 및 감시 체계 개선에 중요한 통찰력을 제공합니다.
Key Message
* This study used text mining of self-reported symptoms following COVID-19 vaccination to identify previously unrecognized adverse reactions.
* Our findings enhance the understanding of vaccine side effects and provide valuable insights for future research and surveillance system improvement.
-
Risk of new-onset seizures following immunization against COVID-19: a self-controlled case-series study
-
Hwa Yeon Ko, Dongwon Yoon, Ju Hwan Kim, Han Eol Jeong, Seung Bong Hong, Won-Chul Shin, Ju-Young Shin, on behalf of the CoVaSC Investigators
-
Epidemiol Health. 2025;47:e2025024. Published online May 2, 2025
-
DOI: https://doi.org/10.4178/epih.e2025024
-
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
Despite emerging reports of new-onset seizures (NOS) following coronavirus disease 2019 (COVID-19) vaccination, safety evidence regarding the risk of NOS after vaccination remains limited. We aimed to investigate the potential association between NOS and COVID-19 vaccination.
METHODS
We conducted a self-controlled case series study utilizing a nationwide database linking the COVID-19 vaccination registry and the National Health Information Database (from February 2021 to October 2022). We identified adults (≥18 years) who received COVID-19 vaccination (BNT162b2, ChAdOx1 nCoV-19, mRNA-1273, NVX-CoV2373, or Ad26.COV2.S) and had a diagnosis of NOS accompanied by prescriptions of anti-seizure drugs. The observation period was defined as 240 days following vaccination. We evaluated the risk of NOS during a risk window of 28 days after vaccination compared to the control window (the remaining observation period excluding the risk window). Incidence rate ratios (IRRs) with 95% confidence intervals (CIs) were estimated using a conditional Poisson regression model.
RESULTS
Among 42,155,198 COVID-19 vaccine recipients, we identified 1,849 and 4,217 patients with NOS in the risk and control windows, respectively. There was no increased risk of NOS within the 28-day period following vaccination (IRR, 0.99; 95% CI, 0.94 to 1.05). Although results from subgroup analyses by vaccine type were largely consistent with the main findings (IRR, 0.95; 95% CI, 0.88 to 1.03 for BNT162b2; IRR, 0.95; 95% CI, 0.77 to 1.16 for ChAdOx1 nCoV-19; IRR, 1.58; 95% CI, 0.52 to 4.83 for Ad26.COV2.S), a marginally elevated risk was observed for mRNA-1273 (IRR, 1.21; 95% CI, 1.04 to 1.42).
CONCLUSIONS
There was no evidence of an increased risk of NOS following COVID-19 vaccination. These findings can be used as safety evidence in clinical decision-making and to bolster public confidence in COVID-19 vaccines.
-
Summary
Korean summary
· 질병관리청 코로나19백신 접종 등록자료와 국민건강보험공단의 청구 데이터베이스 연계 자료원을 활용하여 코로나19백신 접종과 경련/발작 발생 간의 관련성에 대한 안전성 평가를 수행함.
· 자기-대조환자군 연구설계를 적용하여 4,215만 명 이상의 코로나19백신 접종자를 대상으로 분석한 결과, 대부분의 백신 종류에서 접종 후 28일 이내에 경련/발작 발생 위험이 증가하지 않았으며, mRNA-1273 백신에서만 위험이 다소 증가한 것으로 나타남.
· 전반적으로, 본 연구는 코로나19백신 접종 후 경련/발작 발생 위험이 증가하지 않음을 보여주었으며, 이는 임상적 의사결정과 백신 안전성에 대한 신뢰를 높이는 근거로 활용될 수 있음.
Key Message
· A nationwide self-controlled case series study investigated whether COVID-19 vaccination increases the risk of new-onset seizures (NOS) in adults by analyzing over 42 million vaccine recipients.
· The results showed no increased risk of NOS within 28 days after vaccination for most vaccine types, with the exception of a marginally elevated risk for the mRNA-1273 vaccine.
· Overall, the study found no evidence of increased NOS risk following COVID-19 vaccination, supporting the safety of these vaccines for clinical decision-making.
-
Association between the safety climate and occupational injury in the Korean working population: a cross-sectional study
-
Jeehee Min, Tae-Won Jang, Hye-Eun Lee, Mo-Yeol Kang, Seong-Sik Cho
-
Epidemiol Health. 2024;46:e2024082. Published online October 1, 2024
-
DOI: https://doi.org/10.4178/epih.e2024082
-
-
14,596
View
-
203
Download
-
2
Web of Science
-
3
Crossref
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
Preventing occupational injuries remains a significant challenge in Korea. A positive safety climate can contribute to reducing workplace injuries. However, the impact of safety climate on preventing occupational injuries among the Korean workforce has not been adequately explored. Therefore, this study aimed to investigate the relationship between the perceived safety climate and occupational injuries within the Korean working population.
METHODS
This study used baseline data from the Korean Work, Sleep, and Health Study (KWSH). The safety climate was measured using the brief version of the Nordic Safety Climate Questionnaire. Occupational injury was determined by whether injuries or accidents had occurred at workplaces in the past year. Logistic regression analysis was performed to examine the association between the safety climate and occupational injury.
RESULTS
Participants who reported an unfavorable workplace safety climate were more likely to experience occupational injuries. Multiple logistic regression analysis revealed that the adjusted odds ratio (OR) for occupational injuries in an unfavorable safety climate was 2.20 (95% confidence interval [CI], 1.38 to 3.51) compared to a favorable safety climate. Specifically, factors such as “not encouraging employees to follow safety rules when on a tight schedule” (OR, 2.02; 95% CI, 1.25 to 3.24) and “not helping each other work safely” (OR, 1.98; 95% CI, 1.17 to 3.25) were significantly associated with occupational injuries.
CONCLUSIONS
An unfavorable safety climate was associated with increased occupational injuries among Korean workers. Improving the safety climate in the workplace may reduce occupational injuries in Korea.
-
Summary
Korean summary
한국 노동인구집단에서도 안전풍토는 직업성 손상과 관련성이 관찰되었다. 이 같은 결과는 작업장의 안전풍토를 개선함으로써 직업성 손상을 예방할 수 있음을 시사한다.
Key Message
Safety climate was related to occupational injuries in the Korean working population. This result may indicate that occupational injuries can be prevented by improving the workplace safety climate. Workplace safety should be a high priority goal for management, and workers need to help each other for workplace safety.
-
Citations
Citations to this article as recorded by

- Data profile: Korean Work, Sleep, and Health Study (KWSHS)
Seong-Sik Cho, Jeehee Min, Heejoo Ko, Mo-Yeol Kang
Ann Occup Environ Med.2025; 37: e3. CrossRef - Safety Climate and Occupational Injuries in the Iron and Steel Industries in Tanzania
Saumu Shabani, Bente Elisabeth Moen, Teferi Abegaz, Simon Henry Mamuya
International Journal of Environmental Research and Public Health.2025; 22(9): 1372. CrossRef - Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia
Teferi Abegaz, Wakgari Deressa, Bente E. Moen
International Archives of Occupational and Environmental Health.2025; 98(7): 685. CrossRef
-
Risk of lymphadenopathy from SARS-CoV-2 vaccination in Korea: a self-controlled case series analysis
-
Mi-Sook Kim, Bongyoung Kim, Jeong Pil Choi, Nam-Kyong Choi, Jung Yeon Heo, Jun Yong Choi, Joongyub Lee, Sang Il Kim
-
Epidemiol Health. 2023;45:e2023090. Published online October 13, 2023
-
DOI: https://doi.org/10.4178/epih.e2023090
-
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
To assess the risk of lymphadenopathy following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.
METHODS
A self-controlled case series design was used to determine whether the risk of lymphadenopathy was higher in the 1-day to 42-day risk interval after coronavirus disease 2019 (COVID-19) vaccination compared to the control period. In addition, subgroup analyses were conducted according to baseline characteristics, time since vaccination, and sensitivity analyses adjusted for the length of the risk interval.
RESULTS
The risk of developing lymphadenopathy in the risk interval (1-42 days) after COVID-19 vaccination compared to the control period was significantly increased, with a relative incidence (RI) of 1.17 (95% confidence interval [CI], 1.17 to 1.18) when the first, second, and third doses were combined. The RI was greater on the day of vaccination (1.47; 95% CI, 1.44 to 1.50). In subgroup analyses by baseline characteristics, a significantly increased risk or trend toward increased risk was observed in most subgroups except for those aged 70 years and older, with a significant increase in risk in younger individuals, those with a Charlson’s comorbidity index <5, and those who received mRNA vaccines (mRNA-1273>BNT162b2). Within the 1-day to 42-day post-dose risk period, the relative risk was highest during the 1-day to 7-day post-dose period (1.59; 95% CI, 1.57 to 1.60) compared to the control period, and then the risk declined. In the sensitivity analysis, we found that the longer the risk window, the smaller the RI.
CONCLUSIONS
SARS-CoV-2 vaccination is associated with a statistically significant increase in the risk of lymphadenopathy, and this risk was observed only with mRNA vaccines.
-
Summary
Korean summary
질병관리청의 코로나19 예방접종자료와 국민건강보험공단 자료를 이용하여 수행한 본 자기대조환자군 연구에서 코로나19 백신접종은 42일 내 림프절병증 발생위험을 1.17배 (95% 신뢰구간, 1.17-1.18) 증가시키는 것으로 나타났다. 이러한 위험의 증가는 mRNA 백신에 국한하여 관찰되었으며 연령이 낮을수록, 여성일수록 상대위험도가 높은 것으로 나타났다.
Key Message
This self-controlled case series study, using the Korea Disease Control and Prevention Agency COVID-19 vaccination database and the National Health Insurance Service database, showed an increased risk of developing lymphadenopathy following vaccination (RR 1.17; 95% CI, 1.17 to 1.18). The elevated risk of lymphadenopathy is specifically associated with mRNA platform vaccines, not viral vector vaccines, and is more pronounced in younger individuals and females.
-
Estimated trends in hospitalizations due to occupational injuries in Korea based on the Korean National Hospital Discharge In-depth Injury Survey (2006-2019)
-
Seong-Uk Baek, Won-Tae Lee, Min-Seok Kim, Myeong-Hun Lim, Jin-Ha Yoon
-
Epidemiol Health. 2023;45:e2023042. Published online April 5, 2023
-
DOI: https://doi.org/10.4178/epih.e2023042
-
-
15,175
View
-
154
Download
-
1
Crossref
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
In recent years, occupational injuries have sparked a huge social and political debate. Thus, in this study, we focused on the characteristics and trends of occupational injuries requiring hospitalization in Korea.
METHODS
The Korea National Hospital Discharge In-depth Injury Survey was designed to estimate the annual number and characteristics of all injury-related hospitalizations in Korea. The annual number of hospitalizations due to occupational injuries and the age-standardized rates (ASRs) were estimated from 2006 to 2019. The annual percentage change (APC) and average annual percentage change (AAPC) of ASRs and their 95% confidence intervals (CIs) were calculated using joinpoint regression. All analyses were stratified by gender.
RESULTS
In men, the APC of the ASRs of all-cause occupational injuries was -3.1% (95% CI, -4.5 to -1.7) in 2006-2015. However, a non-significant upward trend was observed after 2015 (APC, 3.3%; 95% CI, -1.6 to 8.5). In women, the APC of all-cause occupational injuries was -8.6% (95% CI, -12.1 to -5.1) in 2006-2012. However, a non-significant upward trend was observed after 2012 (APC, 2.1%; 95% CI, -0.9 to 5.2). A recent upward trend in stabbing injuries was observed after 2012 (APC, 4.7%; 95% CI, -1.8 to 11.8) in women. A non-significant overall increasing trend was also observed for occupational injuries caused by exposure to extreme temperatures (AAPC, 3.7%; 95% CI, -1.1 to 8.7) in women.
CONCLUSIONS
A recent upward trend in all-cause injury hospitalizations and hospitalizations caused by stabbing injuries was observed. Therefore, active policy interventions are required to prevent occupational injuries.
-
Summary
Korean summary
본 연구는 퇴원환자 심층조사를 사용하여 2006년부터 2019년까지 우리나라에서 발생한 업무상 손상의 추세를 연령표준화발생률을 구함으로써 분석하였다. 남녀 모두에서 2010년대 초반 까지는 발생률이 유의하게 감소하는 추세를 보였지만, 2013-2015년 이후부터는 통계적으로 유의하지 않은 점진적 상승 추세가 관찰되었다. 이러한 연구 결과는 업무상 손상을 예방하기 위해 적극적인 정책적 개입이 필요하다는 것을 시사한다.
Key Message
This study analyzed the trends in work-related injury occurrences in South Korea from 2006 to 2019 based on a nationally representative, repeated cross-sectional dataset. Age-standardized rates were calculated and their annual trend was estimated using a JointPoint regression. While both males and females exhibited a significant decline in occupational injury rates until the early 2010s, a non-significant but gradual upward trend has been observed since 2013-2015. These findings underscore the need for active policy interventions to prevent work.
-
Citations
Citations to this article as recorded by

- Factors Affecting Mortality and Distribution of Co-morbidities in Chronic Obstructive Pulmonary Disease
Sung-Soo Kim
Journal of Health Informatics and Statistics.2024; 49(1): 35. CrossRef
COVID-19: Brief Communication
-
Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
-
Yunhyung Kwon, Insob Hwang, Mijeong Ko, Hyungjun Kim, Seontae Kim, Soon-Young Seo, Enhi Cho, Yeon-Kyeng Lee
-
Epidemiol Health. 2023;45:e2023006. Published online December 26, 2022
-
DOI: https://doi.org/10.4178/epih.e2023006
-
-
18,835
View
-
180
Download
-
2
Web of Science
-
4
Crossref
-
Abstract
Summary
PDF
-
Abstract
OBJECTIVES
In Korea, a national coronavirus disease 2019 (COVID-19) vaccination program was implemented, including 4 vaccines against COVID-19. A text messaging-based survey, in addition to a passive adverse event reporting system, was launched to quickly report unusual symptoms post-vaccination. This study compared the frequency of adverse events after COVID-19 vaccination based on the vaccine type and the type of 2-dose regimen (homologous or heterologous).
METHODS
Self-reported adverse events were collected through a text-message survey for 7 days after each vaccination. This study included 50,950 vaccine recipients who responded to the survey at least once. Informed consent to receive surveys via text was obtained from the vaccine recipients on the date of first vaccination.
RESULTS
The recipients of mRNA vaccines reported local and systemic reactions 1.6 times to 2.8 times more frequently after dose 2 than after dose 1 (p<0.001), whereas ChAdOx1-S recipients reported significantly fewer local and systemic reactions after dose 2 than after dose 1 (p<0.001). Local and systemic reactions were approximately 2 times and 4 times more frequent for heterologous vaccination than for BNT162b2/BNT162b2 and ChAdOx1-S/ChAdOx1-S regimens, respectively. Young individuals, female, and those receiving heterologous vaccine regimens including ChAdOx1-S/BNT162b2 vaccines reported more adverse events than older participants, male, and those with homologous vaccine regimens.
CONCLUSIONS
Although a heterologous regimen, youth, and female sex were associated with a higher risk of adverse reactions after COVID-19 vaccination, no critical issues were noted. Active consideration of heterologous schedules based on the evidence of efficacy and safety appears desirable.
-
Summary
Korean summary
본 연구는 코로나19 백신 접종 후 7일 동안 문자 설문조사를 통해 50,950명이 자가 보고한 이상반응자료를 분석하였다. mRNA 백신 접종자는1회 접종 후보다 2회 접종 후 국소 이상반응 및 전신이상반응을 1.6~2.8배 더 자주 보고한 반면, ChAdOx1-S 백신 접종자는1회 접종 후 보다 2회 접종 후 이상반응을 더 적게 보고하였다. 동종 백신접종 보다 교차 접종의 경우 2-4배 더 많은 이상반응을 보고 하였다. COVID-19 백신 접종 후 교차접종, 젊은 연령, 여성의 경우 좀 더 많은 이상반응을 보고하였지만,중대한 문제는 보고되지 않았다.
Key Message
Self-reported adverse events were collected through a text-message survey from 50,950 recipients for 7 days after COVID-19 vaccination. The mRNA vaccine recipients reported local and systemic reactions 1.6 to 2.8 times more frequently after dose 2 than after dose 1, whereas ChAdOx1-S recipients reported significantly fewer local and systemic reactions after dose 2 than after dose 1. Local and systemic reactions were approximately 2 to 4 times more frequent for heterologous vaccination than for homologous regimens. Although a heterologous regimen, youth, and female were associated with a higher risk of adverse reac¬tions after COVID-19 vaccination, no critical issues were noted.
-
Citations
Citations to this article as recorded by

- Retinal Vascular Occlusions After COVID-19 Vaccination in South Korea: A Nation-Wide Population-Based Study
Yeji Kim, Kyungdo Han, Jae Hui Kim
Ophthalmic Epidemiology.2025; 32(4): 403. CrossRef - Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa
Azwidihwi Takalani, Michelle Robinson, Phumeza Jonas, Annie Bodenstein, Vuyelo Sambo, Barry Jacobson, Vernon Louw, Jessica Opie, Jonny Peter, Pradeep Rowji, Ishen Seocharan, Tarylee Reddy, Nonhlanhla Yende-Zuma, Kentse Khutho, Ian Sanne, Linda-Gail Bekker
Vaccine.2024; 42(6): 1195. CrossRef - Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea
Mijeong Ko, Seontae Kim, Seok-Kyoung Choi, Seung Hwan Shin, Yeon-Kyeng Lee, Yunhyung Kwon
Osong Public Health and Research Perspectives.2024; 15(4): 364. CrossRef - A Nationwide Survey of mRNA COVID-19 Vaccinee’s Experiences on Adverse Events and Its Associated Factors
Dongwon Yoon, Ha-Lim Jeon, Yunha Noh, Young June Choe, Seung-Ah Choe, Jaehun Jung, Ju-Young Shin
Journal of Korean Medical Science.2023;[Epub] CrossRef
COVID-19: Systematic Review
-
Quality of biosafety guidelines for dental clinical practice throughout the world in the early COVID-19 pandemic: a systematic review
-
Renata Cristina Soares, Juliana Schaia Rocha, Saulo Vinicius da Rosa, Jéssica Rodrigues da Silva Noll Gonçalves, Priscilla Lesly Perlas Condori, Ana Elisa Ribeiro, Samuel Jorge Moysés, Márcia Helena Baldani
-
Epidemiol Health. 2021;43:e2021089. Published online October 22, 2021
-
DOI: https://doi.org/10.4178/epih.e2021089
-
-
25,406
View
-
233
Download
-
5
Web of Science
-
7
Crossref
-
Abstract
Summary
PDF
Supplementary Material
-
Abstract
OBJECTIVES
To conduct a systematic review of coronavirus disease 2019 (COVID-19)-related biosafety guidelines for dental clinical practice in the early stage of the pandemic, focusing on quality assessment.
METHODS
Electronic (via PubMed, Scopus, Web of Science, Latin American and Caribbean Health Sciences Literature database, Brazilian Library in Dentistry, and Cochrane Library) and gray literature searches were performed for documents published up to May 12, 2020. Guidelines updated until April 17, 2021 were identified. Documents were included as guidelines if they (1) consisted of a set of statements, directions, or principles presenting current or future rules or policy; (2) were developed by government agencies, institutions, organizations, or expert panels; and (3) were related to the general conduct of healthcare activities rather a particular condition. Two researchers, using the Appraisal of Guidelines for Research & Evaluation II, independently extracted the recommendations and evaluated the quality of the guidelines.
RESULTS
Twenty-seven documents from 19 countries were included in the review. These documents presented 122 recommendations related to (1) professional biosafety; (2) patients’/companions’ safety; (3) the organization and biosafety of the physical dental facility environment; and (4) the work process in dental care. Overall, the scientific quality of the guidelines was considered low. Some recommendations presented in these guidelines would require further research to establish their effectiveness.
CONCLUSIONS
We found a wide variety of biosafety guidelines for dental practice regarding COVID-19 in the early months of the pandemic, but their quality was low. Biosafety recommendations should be frequently updated.
-
Summary
Key Message
Despite the wide variety of biosafety guidelines for dental practice regarding COVID-19 in the early months of the pandemic, their quality was low. These findings demonstrate the need for more guidelines for dental practice with more high-quality evidence, focusing on clarification of the strictness of development, financing, conflicts of interest, and applicability. Guidelines with high scientific quality are essential for the formation of a robust scientific consensus facilitating the ability to offer safer and more reliable procedures in the pandemic context.
-
Citations
Citations to this article as recorded by

- Quality and applicability of clinical practice guidelines developed for dental implantology: A systematic scoping review
Eduardo Ensaldo-Carrasco, Buket Acar, Hanife Merva Parlak, Meltem Özdemir Kabalak, Nermin Tarhan
Journal of Oral Health and Oral Epidemiology.2025; 14: 2403.1635. CrossRef - Biosafety in public and private dental services in southern Brazil in the first COVID-19 pandemic year
Renata Cristina Soares Fornazari, Manoelito Ferreira Silva-Junior, Cristine Maria Warmling, Renata Goulart Castro, Giovana Daniela Pecharki, Samuel Jorge Moysés, Márcia Helena Baldani
Revista Brasileira de Saúde Ocupacional.2025;[Epub] CrossRef - Biossegurança dos serviços odontológicos público e privado na região Sul do Brasil no primeiro ano da pandemia da covid-19
Renata Cristina Soares Fornazari, Manoelito Ferreira Silva-Junior, Cristine Maria Warmling, Renata Goulart Castro, Giovana Daniela Pecharki, Samuel Jorge Moysés, Márcia Helena Baldani
Revista Brasileira de Saúde Ocupacional.2025;[Epub] CrossRef - Food-Based Dietary Guidelines for Infants in Latin America and the Caribbean: A Systematic Review
Isabelle Cristina Daniel, Mariana Sofia Moro Siqueira, Gabriela Ulbricht Romaneli, Juliana Schaia Rocha Orsi, Renata Iani Werneck
Nutrients.2024; 16(8): 1233. CrossRef - Review on the biosafety measures for the prevention and control of SARS-CoV-2 infections in healthcare settings
Marew ALEMNEW, Birhanu ANDUALEM, Aschalew GELAW, Eyuel KASSA, Addis GETU
Journal of Life Science and Biomedicine.2024; : 30. CrossRef - Knowledge, Attitude, and Practice of Biosafety Guidelines among Dental Undergraduates during COVID-19 Pandemic at a Dental Institution in North Karnataka – An Institution-Based Cross-Sectional Study
Vaishnavi A. Nidarkar, Zameera Naik, S Lokesh Kumar, Anand Badavannavar, Muskan D. Hinduja, Ram Surath Kumar
Journal of Indian Academy of Oral Medicine and Radiology.2024; 36(4): 426. CrossRef - Impact of COVID-19 on Dental Practices in El Salvador and Mexico: A Comprehensive Survey Analysis
Nuria Patiño-Marín, Wendy Yesenia Escobar de González, Katleen Argentina Aguirre de Rodríguez, Miguel Angel Casillas Santana, Carlo Eduardo Medina-Solís, Guillermo Alfonso Aguirre Escobar, Gabriel Alejandro Martínez-Castañón, Marco Salas
Cureus.2023;[Epub] CrossRef